In October, the Labion team participated at Nanomedicine International conference in Milan.
NanoMed aims to give a complete overview of the state of art, the latest results, difficulties and the future trends in nanobiotechnology and nanomedicine.
The event offers to PhD and young researchers the opportunity to discuss the results of their studies and to create new cooperation project.
Dr. Silvia Picciolini presented the results of a study on the application of Surface Plasmon Resonance imaging (SPRi) for the characterization of multiple circulating extracellular vesicles (EVs), isolated from the blood plasma of Alzheimer’s disease patients and a group of healthy subjects. The results showed the possibility to diagnose and monitor the progression of the disease by combining different factors that are involved in the pathology through the multiplexing analysis of plasma EVs. Moreover, the proposed SPRi-based biosensor could be used for the evaluation of the neurodegenerative condition during rehabilitation treatment. Results are published on the Journal of of Pharmaceutical and Biomedical Analysis.
Dr. Francesca Rodà, instead, presented the first data regarding the characterization with biophotonics-techniques of nano-liposomes as therapeutic agents for neurological disorders, as proposed by NEVERMIND project. In particular, Raman Spectroscopy was used to verify the quality of liposome synthesis, whereas SPRi experiments have been performed to evaluate the preservation of the binding affinity to their targets.
